Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
To evaluate azithromycin ocular conjunctiva concentrations 7 and 14 days after treatment
initiation.
To assess ocular and systemic tolerance/safety and azithromycin tear concentrations on Day 7